Every pipeline review, the same question: "What do we need to do to close this?" Every time, the same wrong answer: push harder.

I spent 17 years on the content strategy side of B2B revenue engines, writing the assets that were supposed to move buyers through the funnel. Case studies, one-pagers, ROI calculators, competitive battle cards. All of it built on a shared assumption: if the buyer has enough information and the right nudge, they'll decide.

They don't. Not most of them.

And then the deal went quiet. Not lost to a competitor. Not killed by budget. Just... silent. That silence has a name, and it isn't "ghosting." It's the buyer readiness gap.

The No-Decision Problem Is Bigger Than Your Pipeline Thinks

The single largest category of lost B2B revenue isn't competitive loss. It's no decision.

Dixon and McKenna's analysis of 2.5 million recorded sales conversations found that between 40% and 60% of qualified deals end this way. Not a polite "we went with someone else." Not a budget cut. The buyer simply never completed the decision. Ebsta and Pavilion's 2024 benchmark, covering $54 billion in pipeline data, put the number at 61% of lost deals attributed to buyer indecision.

Sit with that number for a second. More than half of your losses aren't losses at all. They're unfinished decisions.

I wrote content for teams drowning in this pattern for years before I could name it. The demos looked great. The follow-up emails were sharp. The champions were enthusiastic. And then: nothing. When I finally stopped looking at what sellers were doing and started looking at what buyers weren't deciding, the whole picture shifted.

Indecision Is Not Status Quo Preference (and the Difference Changes Everything)

Here's where most sales teams get the diagnosis wrong. They treat every stalled deal as a buyer who chose to stay put. The status quo won. So the playbook says: relitigate the status quo. Restate the pain. Push the cost of inaction.

Dixon and McKenna's research splits no-decision losses into two distinct categories: 44% are genuine status quo preference (the buyer evaluated change and chose not to), and 56% are buyer indecision (the buyer wanted to act but couldn't resolve their own hesitation).

That distinction is everything. Status quo preference and indecision require opposite interventions. For status quo buyers, relitigating the cost of inaction makes sense. For indecisive buyers, it makes things worse.

And here's the kicker: 73% of sellers default to relitigating the status quo when deals stall. They're applying the right treatment to the wrong condition for more than half of their stalled pipeline.

The teams I watched make this mistake weren't bad at sales. They were blind to the distinction. Nobody had given them an instrument to tell the difference between a buyer who chose to stay and a buyer who couldn't figure out how to leave.

Four Readiness Gaps That Predict Where Deals Die

If indecision is the disease, it's not one disease. It's four.

After 17 years of watching B2B deals die from the content seat, patterns became unavoidable. The same failure modes kept repeating, and they weren't random. Each one mapped to a specific gap in the buyer's ability to decide. I built the four-dimension framework to make those gaps visible before they kill the deal.

Problem Conviction. Does the buyer believe the problem justifies action? Kahneman and Tversky's prospect theory established that buyers feel losses approximately 2.25 times more intensely than equivalent gains. But loss aversion only works if the buyer has internalized the loss. When conviction is missing, the deal stalls because "doing nothing" still feels safe.

Evaluation Clarity. Does the buyer have a structured framework for comparing options? Gartner's research found that when buyers face too much high-quality but contradictory information, they're 153% more likely to settle for a smaller, less disruptive solution than originally planned. Information overload doesn't produce better decisions. It produces smaller ones.

Outcome Confidence. Does the buyer trust that this specific solution will work in their specific environment? Forrester's 2024 research found that 43% of B2B buyers make defensive purchase decisions more than 70% of the time. Defensive buying isn't rational evaluation. It's a buyer protecting themselves from blame.

Organizational Readiness. Can the buying group actually align and close? Forrester puts the average B2B buying group at 13 stakeholders across multiple departments. Gartner found that 74% of buyer teams demonstrate unhealthy conflict during the decision process. Your champion might be ready. Their organization isn't.

I watched deals die in each of these four ways. What I couldn't do, until I built the diagnostic, was tell which one was killing a specific deal before it was too late.

These four dimensions form a chain. The deal moves at the speed of the weakest link. Three maxed dimensions plus one incomplete dimension equals a dead deal. That's the buyer readiness gap in practice: the distance between "qualified" and "ready to decide."

Why Selling Harder Makes It Worse

The default response to a stalled deal in most B2B organizations is pressure. More emails. More check-in calls. Another "just following up." A discounted offer with a deadline.

Dixon and McKenna's data on this is unforgiving. Pushing harder on indecisive buyers degrades win rates by 84%. The harder you push, the further the buyer retreats into omission bias: the psychological tendency to prefer inaction over action when action might produce regret.

The teams I watched default to pressure weren't wrong to try it. They just had no other instrument. When the only tool you have is "sell harder," every stalled deal looks like a closing problem.

But contrast that with what actually works. Dixon and McKenna found a 144% win-rate improvement when sellers offered proactive guidance rather than more options. 155% improvement from setting clear outcome expectations upfront. And only 19% of sales calls actually include this behavior.

The gap between what works and what most teams do is staggering. Not because sellers are lazy. Because they're diagnosing stalled deals with tools that can't distinguish between a buyer who chose "no" and a buyer who couldn't figure out how to choose "yes."

What Measuring Buyer Readiness Actually Changes

The shift isn't about selling differently. It's about seeing differently.

I built the four-dimension diagnostic because I got tired of writing post-mortems on deals that should have been diagnosed before the demo ever happened. When you measure buyer readiness across those four dimensions before the demo, the entire pipeline equation changes. You stop reacting to ghosting after the fact. You start diagnosing the specific gap that will kill the deal before the buyer goes quiet.

The data backs this up. Dixon and McKenna found a 14% close rate when sellers only diagnosed the problem without prescribing a resolution. But when diagnosis was paired with a specific protocol recommendation, close rates jumped to 36%. Diagnosis alone isn't enough. Diagnosis plus the right intervention for the right gap is what moves the number.

This is DecisionScope: a diagnostic layer that sits beneath whatever qualification process your team already runs, whether that's MEDDIC, BANT, Challenger, or something you built yourself. Those processes tell you whether the deal conditions are right. DecisionScope tells you whether the buyer has actually completed the internal work required to say yes.

A deal can pass every qualification criterion and still die because the buyer never resolved their outcome uncertainty. That's the readiness gap. And now there's a way to measure it.

Take the free Buyer Readiness Check and score your pipeline across four dimensions in under five minutes.